🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/12/2006 23,46 23,58 22,50 22,98 -2,54% 4,60% 95.983
05/12/2006 23,64 23,70 22,56 23,58 -0,51% 4,82% 90.767
04/12/2006 23,88 25,02 23,16 23,70 +10,03% 7,79% 339.017
01/12/2006 21,72 21,84 21,30 21,54 -1,10% 2,49% 55.483
30/11/2006 21,84 21,90 21,36 21,78 +0,00% 2,47% 40.783
29/11/2006 21,48 22,56 21,30 21,78 +1,40% 5,87% 90.817
28/11/2006 21,72 22,14 21,30 21,48 -1,65% 3,87% 72.833
27/11/2006 22,62 22,92 21,48 21,84 -3,45% 6,37% 136.500
24/11/2006 21,90 23,22 21,66 22,62 +2,45% 7,12% 70.550
22/11/2006 22,50 22,74 22,02 22,08 -1,87% 3,20% 38.800
21/11/2006 22,92 22,92 22,50 22,50 -1,32% 1,83% 55.350
20/11/2006 22,74 23,16 22,50 22,80 -0,52% 2,90% 44.417
17/11/2006 23,04 23,22 22,56 22,92 -0,52% 2,86% 65.883
16/11/2006 23,10 23,28 22,86 23,04 -0,78% 1,82% 47.050
15/11/2006 23,58 23,70 22,68 23,22 -0,77% 4,33% 95.433
14/11/2006 23,04 23,88 22,20 23,40 +1,83% 7,29% 140.567
13/11/2006 22,32 23,16 22,26 22,98 +2,13% 4,03% 65.617
10/11/2006 22,80 23,10 21,90 22,50 +1,63% 5,26% 119.350
09/11/2006 23,16 23,40 21,30 22,14 -4,90% 9,07% 152.150
08/11/2006 23,70 23,88 22,92 23,28 -2,27% 4,05% 110.683
07/11/2006 23,40 24,78 23,28 23,82 +0,76% 6,41% 157.200
06/11/2006 22,62 24,00 22,32 23,64 +4,51% 7,43% 153.133
03/11/2006 22,38 23,28 22,38 22,62 +1,89% 4,02% 137.050
02/11/2006 22,80 22,92 21,90 22,20 -3,90% 4,47% 118.967
01/11/2006 23,16 24,12 22,98 23,10 -0,77% 4,92% 116.133
31/10/2006 24,72 24,96 23,10 23,28 -3,48% 7,52% 197.350
30/10/2006 24,72 25,62 23,76 24,12 -2,90% 7,52% 189.750
27/10/2006 26,40 26,70 24,72 24,84 -3,50% 7,50% 196.700
26/10/2006 25,68 26,64 25,50 25,74 +0,00% 4,44% 179.867
25/10/2006 26,70 27,30 25,50 25,74 -2,94% 6,74% 197.483